Single therapeutic and supratherapeutic doses of corifollitropin alfa, a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers.

Share

First published in Int. Journal of Clinical Pharmacology and Therapeutics on 2015 Sep.
Int J Clin Pharmacol Ther. 2015 Sep;53(9):772-82. doi: 10.5414/CP202363.

Authors: de Kam PJ, van Kuijk JH, Zandvliet AS, Thomsen T

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File